tiprankstipranks
AlloVir (ALVR)
NASDAQ:ALVR
US Market
Holding ALVR?
Track your performance easily

AlloVir (ALVR) Income Statement

344 Followers

AlloVir Income Statement

Last quarter (Q3 2024), AlloVir's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, AlloVir's net income was $-4.13M. See AlloVir’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-----$ 165.00K
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 108.36M$ 181.33M$ 171.20M$ 169.82M$ 71.31M$ 26.87M
Operating Income
$ -108.20M$ -199.90M$ -171.20M$ -169.82M$ -71.31M$ -26.70M
Net Non Operating Interest Income Expense
$ 5.47M$ 5.73M$ 1.88M$ 1.31M$ 1.33M$ 2.06M
Other Income Expense
$ -2.40M$ -14.95M$ 351.00K$ 2.45M$ -195.00K$ 797.00K
Pretax Income
$ -100.57M$ -190.54M$ -168.97M$ -170.96M$ -69.78M$ -23.84M
Tax Provision
$ -126.00K$ -126.00K$ -265.00K$ 1.01M$ -1.94M-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -100.20M$ -190.42M$ -168.71M$ -171.96M$ -69.78M$ -23.84M
Basic EPS
$ -0.87$ -1.83$ -2.20$ -2.74$ -2.59$ -0.64
Diluted EPS
$ -0.87$ -1.83$ -2.20$ -2.74$ -2.59$ -0.64
Basic Average Shares
$ 459.62M$ 104.06M$ 76.65M$ 62.78M$ 26.90M$ 37.10M
Diluted Average Shares
$ 459.62M$ 104.06M$ 76.65M-$ 26.90M$ 37.10M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 108.36M$ 181.33M$ 171.20M$ 169.82M$ 71.31M$ 26.87M
Net Income From Continuing And Discontinued Operation
$ -100.20M$ -190.42M$ -168.71M$ -171.96M$ -69.80M$ -23.84M
Normalized Income
$ -34.53M$ -155.50M---$ -23.84M
Interest Expense
------
EBIT
$ -76.90M$ -181.33M$ -171.20M$ -169.82M$ -71.31M$ -26.70M
EBITDA
$ -76.76M$ -180.93M$ -170.48M$ -169.63M$ -71.24M$ -26.68M
Currency in USD

AlloVir Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis